The management of brain-dead organ donors is complex. The use of inotropic agents and
replacement of depleted hormones (hormonal replacement therapy) is crucial for successful …

Background Hormonal therapy to the brain-dead potential organ donor can include thyroid
hormone (triiodothyronine [T 3] or levothyroxine [T 4]), corticosteroids, antidiuretic hormone …

Background Refinements in donor management have resulted in increased numbers and
quality of grafts after neurologic death. We hypothesize that the increased use of hormone …

BACKGROUND Organ shortage is an ongoing problem in the United States. Most donor
organs are procured following brain death and a significant portion of brain-dead donors …

Data from the Organ Procurement and Transplantation Network/United Network for Organ
Sharing database indicate that hormonal therapy of the brain-dead potential organ donor (in …

The aggressive management of brain‐dead (cadaveric) organ donors has been shown to
increase organs available for transplantation. Some centers use hormone therapy with …

Introduction The rate of organ donations from deceased donors in Turkey is among the
lowest in the world. We analyzed the reasons why some potential donors whose families …

The disparity between the number of patients in need of organ transplantation and the
number of available organs is steadily rising. We hypothesized that intensivist‐led …

As of August 2007, 96 900 people are awaiting organ transplantation in the United States,
while only 28 930 transplants were performed in 2006. With such a large gap between …

BACKGROUNDS: Potential deceased donor management optimization is important for
organ recovery maximization. Before optimization, the current state of donor management …